Home LiteratureArticle Details
PMID: 24025256 Published · ppublish English

PARP inhibitors are not all equal.

Cancer biology & therapy ·Vol. 14 ·No. 10 ·2014-06-10

Dent Paul

Abstract

To many investigators PARP1 is simply a substrate for caspase 3, and whose cleavage is thought indicative of apoptosis. However, in reality PARP1 plays a major role in the biology of the cell cycle and DNA repair. (1)(,) (2) PARP1 binds to damaged DNA where it becomes enzymatically activated and ADP ribosylates itself and other proteins. PARP facilitates DNA repair complex formation, e.g., with BRCA1/2, and the activation of the cell cycle regulatory enzymes ATM and ATR. (2) PARP inhibitors as a single agent have only shown any degree of efficacy in breast and ovarian cancer patients who lack BRCA1/2 function. (3)(,) (4) The present studies examined PARP1 inhibitor biology in a range of triple negative and non-triple negative breast cancer cell lines.

Keywords
CDK1 PARP inhibitors RO-3306 breast cancer iniparib olaparib triple-negative
Article Info
Journal
Cancer biology & therapy
Abbr.
Cancer Biol Ther
Published
2014-06-10
Indexed
2013-10-28
Updated
2016-10-19
Language
English
Country/Region
United States
NLM ID
101137842
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com